Eligibility Rheumatoid Arthritis NCT02219347

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
clinical diagnosis of rheumatoid arthritis made by consultant rheumatologist at least 12 months previously
Beschreibung

ID.1

Datentyp

boolean

current single or combination use of methotrexate, sulphasalazine and/or hydroxychloroquine
Beschreibung

ID.2

Datentyp

boolean

arthritis currently in remission, as judged clinically by referring healthcare professional
Beschreibung

ID.3

Datentyp

boolean

willing to consider dmard withdrawal
Beschreibung

ID.4

Datentyp

boolean

Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of biologic therapy within the past 6 months
Beschreibung

ID.5

Datentyp

boolean

received steroids within past 3 months (enteral, parenteral or intra-articular)
Beschreibung

ID.6

Datentyp

boolean

use of any dmard other than methotrexate, sulphasalazine or hydroxychloroquine within the past 6 months (or past 12 months for leflunomide)
Beschreibung

ID.7

Datentyp

boolean

current pregnancy, or pregnancy planned within next 6 months
Beschreibung

ID.8

Datentyp

boolean

current participation within another clinical trial
Beschreibung

ID.9

Datentyp

boolean

inability to provide informed consent
Beschreibung

ID.10

Datentyp

boolean

Ähnliche Modelle

Eligibility Rheumatoid Arthritis NCT02219347

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
clinical diagnosis of rheumatoid arthritis made by consultant rheumatologist at least 12 months previously
boolean
ID.2
Item
current single or combination use of methotrexate, sulphasalazine and/or hydroxychloroquine
boolean
ID.3
Item
arthritis currently in remission, as judged clinically by referring healthcare professional
boolean
ID.4
Item
willing to consider dmard withdrawal
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
use of biologic therapy within the past 6 months
boolean
ID.6
Item
received steroids within past 3 months (enteral, parenteral or intra-articular)
boolean
ID.7
Item
use of any dmard other than methotrexate, sulphasalazine or hydroxychloroquine within the past 6 months (or past 12 months for leflunomide)
boolean
ID.8
Item
current pregnancy, or pregnancy planned within next 6 months
boolean
ID.9
Item
current participation within another clinical trial
boolean
ID.10
Item
inability to provide informed consent
boolean